Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Checkmate Pharmaceuticals, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 0 | May 31, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CMPI | Checkmate Pharmaceuticals, Inc. | May 31, 2022 | 1 | $0 | 4 | May 31, 2022 | Chief Executive Officer, Director |
CMPI | Checkmate Pharmaceuticals, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 2, 2022 | Chief Executive Officer, Director |
CMPI | Checkmate Pharmaceuticals, Inc. | Mar 1, 2022 | 0 | $0 | 3 | Mar 2, 2022 | Chief Executive Officer, Director |